Allegion reported third-quarter 2026 revenue of $1,172.6 million, up 9.6%, and diluted EPS of $2.59, up from $2.18 a year earlier. The company raised its full-year 2026 adjusted EPS outlook to $9.05 to $9.10 and its reported revenue growth outlook to 9.5% to 10.5%, which shareholders can use to gauge the company's expected earnings for the year.
Q3 2026 diluted EPS was $2.59 versus $2.18; adjusted EPS was $2.60, up 13.0%
Q3 organic revenue rose 7.2%, led by the Americas region, where adjusted operating margin reached 30.1%
International segment organic revenue fell 0.2% and its adjusted operating margin declined to 13.9%
In Q3 the company repurchased about 0.8 million shares for about $120 million and paid dividends of about $46 million
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Allegion's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$4.07B
+7.8%
$7.44
+9.1%
15.8%
FY2024
$3.77B
+3.3%
$6.82
+11.4%
15.8%
FY2023
$3.65B
+11.6%
$6.12
+17.9%
14.8%
FY2022
$3.27B
+14.1%
$5.19
-2.8%
14.0%
FY2021
$2.87B
+5.4%
$5.34
+57.5%
16.8%
Frequently asked questions
When is Allegion's next earnings date?
Allegion has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Allegion earn last quarter?
For the quarter ended Sep 2026, Allegion reported diluted EPS of $2.59 (+18.8% year over year) on revenue of $1.17B (+9.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.